Jennie P. Mather
Director/Board Member at A&G Pharmaceutical, Inc.
Profile
Jennie P.
Mather was the founder of Raven Biotechnologies, Inc. which was founded in 1999 where she held the title of President & Chief Scientific Officer.
Currently, she is a Director at A&G Pharmaceutical, Inc. where she is still employed.
Previously, she worked as a Scientist at Genentech, Inc. from 2011 to 2012, as a Senior Vice President-Stem Cell Research at MacroGenics, Inc., and as an Assistant Professor at The Rockefeller University.
Dr. Mather received her undergraduate degree from Brandeis University and her doctorate from the University of California San Diego.
Jennie P. Mather active positions
| Companies | Position | Start |
|---|---|---|
A&G Pharmaceutical, Inc.
 A&G Pharmaceutical, Inc. BiotechnologyHealth Technology A&G Pharmaceutical, Inc. develops and creates monoclonal antibodies to cancer-specific targets. It focuses on a near-term opportunity to complete development of and commercialize two GP88-based breast cancer diagnostic test kits to improve early detection, diagnosis and treatment of breast cancer. The firm's product Theranostics develops molecular diagnostic tests in tandem with targeted therapeutics. The company was founded by Jun Hayashi, Ginette Serrero, and Gordon H. Sato in June 2000 and is headquartered in Columbia, MD. | Director/Board Member | - |
Former positions of Jennie P. Mather
| Companies | Position | End |
|---|---|---|
Raven Biotechnologies, Inc.
 Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | Founder | - |
| The Rockefeller University | Corporate Officer/Principal | - |
| MACROGENICS, INC. | Chief Tech/Sci/R&D Officer | 2011-12-27 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Training of Jennie P. Mather
| Brandeis University | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MACROGENICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | Commercial Services |
A&G Pharmaceutical, Inc.
A&G Pharmaceutical, Inc. BiotechnologyHealth Technology A&G Pharmaceutical, Inc. develops and creates monoclonal antibodies to cancer-specific targets. It focuses on a near-term opportunity to complete development of and commercialize two GP88-based breast cancer diagnostic test kits to improve early detection, diagnosis and treatment of breast cancer. The firm's product Theranostics develops molecular diagnostic tests in tandem with targeted therapeutics. The company was founded by Jun Hayashi, Ginette Serrero, and Gordon H. Sato in June 2000 and is headquartered in Columbia, MD. | Health Technology |
- Stock Market
- Insiders
- Jennie P. Mather
